Page 248 - Read Online
P. 248

Mascarenhas et al. J Cancer Metastasis Treat 2020;6:23              Journal of Cancer
               DOI: 10.20517/2394-4722.2020.52                           Metastasis and Treatment




               Original Article                                                              Open Access


               Lobe-specific modulation of B16MET melanoma
               lung metastases by nephrilin peptide



               Desmond D. Mascarenhas , Puja Ravikumar , Edward P. Amento 3
                                                      3
                                      1,2
               1 Mayflower Organization for Research & Education, Sunnyvale, CA 94085, USA.
               2 Transporin, Inc., Sunnyvale, CA 94085, USA.
               3 Molecular Medicine Research Institute, Sunnyvale, CA 94085, USA.

               Correspondence to: Desmond D. Mascarenhas, Ph.D., Mayflower Organization for Research & Education, 428 Oakmead Pkwy,
               Sunnyvale, CA 94085, USA. E-mail: desmond@transporin.com
               How to cite this article:  Mascarenhas  DD,  Ravikumar  P,  Amento  EP.  Lobe-specific  modulation  of  B16MET  melanoma  lung
               metastases by nephrilin peptide. J Cancer Metastasis Treat 2020;6:23. http://dx.doi.org/10.20517/2394-4722.2020.52
               Received: 17 May 2020    First Decision: 24 Jun 2020    Revised: 24 Jun 2020    Accepted: 06 Jul 2020    Published: 30 Jul 2020

               Academic Editor: Rafat A. Siddiqui    Copy Editor: Cai-Hong Wang    Production Editor: Jing Yu



               Abstract
               Aim: Nephrilin peptide modulates systemic immune responses to trauma in contexts characterized by
               simultaneous inflammation and immunosuppression. This study explores the possibility that nephrilin
               peptide may modulate lung metastasis, which also occurs in an environment of concurrent inflammation and
               immunosuppression.

               Methods: B16MET melanoma cells were injected via the tail vein of mice and the development of lung metastases
               was recorded in animals treated with nephrilin peptide or vehicle by subcutaneous bolus injection daily for three
               weeks. In a separate experiment, nephrilin was administered by subcutaneous bolus injection for seven days to
               study the biodistribution of peptide and possible changes to plasma cytokine levels.

               Results: Nephrilin significantly suppressed B16MET lung metastases. Suppression was more effective in deep lobes
               with the poorest access to circulation: accessory > inferior > middle > superior. In a separate biodistribution study
               in mice, nephrilin showed similar biodistribution levels in kidney, liver, brain, and left lung, but significantly higher
               accumulation in the lobes of the right lung in a gradient that matched its effectiveness in suppressing metastases
               (accessory > inferior > middle). The latter environments were also characterized by significantly higher local
               concentrations of succinate, a proxy for lower levels of oxygenation.

               Conclusion: Nephrilin accumulates preferentially in the deep lobes of the right lung in mice and inhibits B16MET
               right lung metastases in a lobe-specific manner.

                           © The Author(s) 2020. Open Access This article is licensed under a Creative Commons Attribution 4.0
                           International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
                sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long
                as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license,
                and indicate if changes were made.


                                                                                                                                                  www.jcmtjournal.com
   243   244   245   246   247   248   249   250   251   252   253